Proximal Femur Fractures Clinical Trial
Official title:
Our Experience in the Management of Therapeutic Failures of Fractures of the Proximal End of the Femur (About 35 Cases)
Verified date | April 2024 |
Source | Ibn Jazzar Hospital |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Observational |
Osteosyntheses employed in treating fractures at the upper end of the femur play a critical role in facilitating a swift recovery by minimizing immobilization periods and enabling early rehabilitation of the affected joints, thereby promoting a speedy return to normal walking function. Osteosynthesis alters the mechanical dynamics of the bone segment, which undergoes continual changes during the consolidation and mobilization phases of recovery. Throughout these stages, a range of mechanical complications may arise, posing challenges despite the successful prevention of infections. Non-infectious complications associated with the presence of osteosynthesis materials, especially in weight-bearing areas like the lower limb, remain a concern. In light of these considerations, surgeons must exercise meticulous care in selecting synthetic materials to mitigate the risk of osteosynthesis failures. In cases where internal fixation fails, the standard recourse often involves converting to total hip arthroplasty (THA). However, it is essential to note that THA subsequent to complications arising from proximal femur osteosynthesis presents a higher incidence of both intraoperative and postoperative complications compared to the implantation of primary total hip prostheses. Thus, while osteosynthesis remains a valuable intervention for femur fractures, careful attention to material selection and postoperative management is crucial in optimizing patient outcomes and minimizing complications.
Status | Completed |
Enrollment | 35 |
Est. completion date | December 2, 2021 |
Est. primary completion date | December 1, 2021 |
Accepts healthy volunteers | No |
Gender | All |
Age group | N/A and older |
Eligibility | Inclusion Criteria: - • Diagnosis of a fracture of the proximal end of the femur. - Subsequent surgical intervention(s) due to failure of initial surgical treatment Exclusion Criteria: - • Those initially treated with total hip arthroplasty. - Patients lost to follow-up, not consistently monitored, or untreated after diagnosis of the complication. - Cases with incomplete medical records |
Country | Name | City | State |
---|---|---|---|
Tunisia | IBN jazzar hospital | Kairouan |
Lead Sponsor | Collaborator |
---|---|
Ibn Jazzar Hospital |
Tunisia,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Surgical Approach | type of approach | from enrollment to the of treatment 6 years | |
Primary | Preparation of the Patient | type of preparation | from enrollment to the of treatment 6 years | |
Primary | Anesthesia | type of anesthesia | from enrollment to the of treatment 6 years | |
Primary | Type of Surgical Revision | material implanted for revision | from enrollment to the of treatment 6 years | |
Primary | Types of Prosthesis | prothesis used | from enrollment to the of treatment 6 years | |
Secondary | Age Distribution | The average age of patients experiencing therapeutic failure after surgical treatment of proximal femur fractures was 66 years, with ages ranging from 28 to 94 years. The age group 50-90 years constituted 68.59% of cases. | from enrollment to the end of treatment 6 years | |
Secondary | Distribution by Sex | Females represented a slight majority in the study, accounting for 57% (20 women), while males comprised 43% (15 men). | from enrollment to the end of treatment 6 years | |
Secondary | Distribution According to Affected Side | The right side was affected in 60% (21 cases), while the left side was affected in 40% (14 cases). | from enrollment to the end of treatment 6 years | |
Secondary | Distribution According to Circumstances of Trauma | Fractures were predominantly due to minimal trauma, with rare occurrences related to road accidents or domestic falls, attributed to bone fragility and muscle atrophy. One case of a pathological fracture was observed in a patient with dislocation of an intermediate hip prosthesis due to ovarian cancer. | from enrollment to the end of treatment 6 years |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT01660490 -
Development and Validation of Intraoperative Image-quality Criteria
|
N/A | |
Completed |
NCT02696915 -
Fascia Iliaca Compartment Block for Proximal-end Femur Fractures
|
N/A |